X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Americas

ACG expands its footprint in Brazil

Content Team by Content Team
28th February 2019
in Americas, Manufacturing, News
ACG expands its footprint in Brazil

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The USD 94-mn factory spans an area of 14,000 sq metres and is projected to generate around 500 new jobs locally.

Selwyn Noronha, CEO, ACG Capsules, said, “ACG Capsules is one of the largest capsule manufacturers in the world, servicing pharmaceutical and nutraceutical customers in more than 100 countries. The company already has a significant presence in Latin America, and following this investment, ACG will further be able to meet the growing requirements of the region.”

With this investment, ACG has established its second manufacturing facility in Latin America, after the acquisition of Nova Nordeplast in 2017.

The new facility complies with the standards defined by the Brazilian health regulatory agency ANVISA and GMP regulatory bodies.

Both, Nova Nordeplast and the new capsule plant will enable ACG to offer faster response times to its customers in the same region and to its neighbouring countries.

ACG Capsules has also pioneered printing on hard capsules that allows the pharmaceutical companies to create brand differentiation in the market and thwart the threat of counterfeit or falsified drugs.

Roberson Petrungaro, commercial director – Latin America, ACG Capsules, said, “ACG is extremely proud of this new state-of-the-art facility, which demonstrates our long-term commitment to Brazil. As the fifth largest pharmaceutical market in the world, Brazil is a key strategic one for ACG. And the benefit of having local manufacturing will certainly strengthen ties with our customers.”

ACG consists of another operation arm in Brazil known as the ACG Films & Foils, which is located in the state of São Paulo, in the city of Cotia. This unit caters to the pharmaceutical, food & FMCG industry.

It offers specialised primary pharmaceutical packaging including aluminium-based range, special packaging films, high barrier, and polymer films, with all the products being in compliance with FDA, Europe Pharmacopeia and CFDA standards.

Previous Post

CRISPR and Vertex treat first patient in gene-editing therapy trial

Next Post

Pfizer's new partnership focuses on digitising clinical trials

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post
Pfizer’s new partnership focuses on digitising clinical trials

Pfizer's new partnership focuses on digitising clinical trials

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In